AAAAAA
Results: 1-25/33
Authors:
Harris, JE
Desai, N
Seaver, KE
Watson, RT
Kane-Maguire, NAP
Wheeler, JF
Citation: Je. Harris et al., Chiral separations of transition metal complexes using capillary zone electrophoresis, J CHROMAT A, 919(2), 2001, pp. 427-436
Authors:
Harris, JE
Citation: Je. Harris, Re: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial, J NAT CANC, 93(12), 2001, pp. 950-951
Authors:
Anderson, KM
Harris, JE
Citation: Km. Anderson et Je. Harris, Selected features of nonendocrine pancreatic cancer, EXP BIOL ME, 226(6), 2001, pp. 521-537
Authors:
Lyons, JD
Alibazoglu, B
Harris, JE
Ali, A
Hollinger, EF
Citation: Jd. Lyons et al., Pelvic metastases from pancreatic carcinoma - A pattern observed on bone scan, CLIN NUCL M, 26(3), 2001, pp. 230-231
Authors:
Anderson, KM
Harris, JE
Citation: Km. Anderson et Je. Harris, Is induction of type 2 programmed death in cancer cells from solid tumors directly related to mitochondrial mass?, MED HYPOTH, 57(1), 2001, pp. 87-90
Authors:
Anderson, KM
Harris, JE
Citation: Km. Anderson et Je. Harris, Comments on the unreasonable effectiveness of the biological and especially medical sciences, MED HYPOTH, 56(4), 2001, pp. 431-433
Authors:
Ou, D
Bonomi, P
Jao, W
Jadko, S
Harris, JE
Anderson, KM
Citation: D. Ou et al., The mode of cell death in H-358 lung cancer cells cultured with inhibitorsof 5-lipoxygenase or the free radical spin trap, NTBN, CANCER LETT, 166(2), 2001, pp. 223-231
Authors:
Hanna, MG
Hoover, HC
Vermorken, JB
Harris, JE
Pinedo, HM
Citation: Mg. Hanna et al., Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise, VACCINE, 19(17-19), 2001, pp. 2576-2582
Authors:
Kulman, JD
Harris, JE
Xie, L
Davie, EW
Citation: Jd. Kulman et al., Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues, P NAS US, 98(4), 2001, pp. 1370-1375
Authors:
Witte, RS
Cnaan, A
Mansour, EG
Barylak, E
Harris, JE
Schutt, AJ
Citation: Rs. Witte et al., Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resectionfor colorectal carcinoma, CANCER, 91(5), 2001, pp. 1020-1028
Authors:
Harris, JE
Draper, HL
Rhodes, AI
Stevens, JM
Citation: Je. Harris et al., High yield criteria for emergency cranial computed tomography in adult patients with no history of head injury, J AC EMER M, 17(1), 2000, pp. 15-17
Authors:
Cance, WG
Harris, JE
Iacocca, MV
Roche, E
Yang, XH
Chang, JL
Simkins, S
Xu, LH
Citation: Wg. Cance et al., Immunohistochemical analyses of focal adhesion kinase expression in benignand malignant human breast and colon tissues: Correlation with preinvasiveand invasive phenotypes, CLIN CANC R, 6(6), 2000, pp. 2417-2423
Authors:
Plate, JMD
Harris, JE
Citation: Jmd. Plate et Je. Harris, Immune cell functions in pancreatic cancer, CR R IMMUN, 20(5), 2000, pp. 375-392
Authors:
Biener, L
Harris, JE
Hamilton, W
Citation: L. Biener et al., Impact of the Massachusetts tobacco control programme: population based trend analysis, BR MED J, 321(7257), 2000, pp. 351-354
Authors:
Shulman, M
Harris, JE
Lubenow, TR
Nath, HA
Ivankovich, AD
Citation: M. Shulman et al., Comparison of epidural butamben to celiac plexus neurolytic block for the treatment of the pain of pancreatic cancer, CLIN J PAIN, 16(4), 2000, pp. 304-309
Authors:
Harris, JE
Ryan, L
Hoover, HC
Stuart, RK
Oken, MM
Benson, AB
Mansour, E
Haller, DG
Manola, J
Hanna, MG
Citation: Je. Harris et al., Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group study E5283, J CL ONCOL, 18(1), 2000, pp. 148-157
Authors:
Anderson, KM
Alrefai, WA
Anderson, CA
Bonomi, P
Harris, JE
Citation: Km. Anderson et al., Widespread countervailing genomic responses induced by chemotherapy or radiation as a cause of therapeutic failure, MED HYPOTH, 54(6), 2000, pp. 1000-1002
Authors:
Anderson, KM
Alrefai, WA
Bonomi, PA
Anderson, CA
Dudeja, P
Harris, JE
Citation: Km. Anderson et al., A genomic response of H-358 bronchiolar carcinoma cells to MK 886, an inhibitor of 5-lipoxygenase, assessed with a cDNA array, ANTICANC R, 20(4), 2000, pp. 2433-2439
Authors:
Gooding, SR
Winn, PJ
Maurer, RI
Ferenczy, GG
Miller, JR
Harris, JE
Griffiths, DV
Reynolds, CA
Citation: Sr. Gooding et al., Fully polarizable QM/MM calculations: An application to the nonbonded iodine-oxygen interaction in dimethyl-2-iodobenzoylphosphonate, J COMPUT CH, 21(6), 2000, pp. 478-482
Authors:
Berlin, JD
Adak, S
Vaughn, DJ
Flinker, D
Blaszkowsky, L
Harris, JE
Benson, AB
Citation: Jd. Berlin et al., A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296), ONCOL-BASEL, 58(3), 2000, pp. 215-218
Authors:
Yong, AA
Harris, JE
Shorvon, PJ
Citation: Aa. Yong et al., The value of prone imaging in CT pneumocolon, CLIN RADIOL, 55(12), 2000, pp. 959-963
Authors:
Harris, JE
Chan, SW
Citation: Je. Harris et Sw. Chan, The continuum-of-addiction: Cigarette smoking in relation to price among Americans aged 15-29, HEALTH ECON, 8(1), 1999, pp. 81-86
Authors:
Wiernik, PH
Gordon, LI
Oken, MM
Harris, JE
O'Connell, MJ
Citation: Ph. Wiernik et al., Evaluation of mitoguazone in patients with refractory chronic lymphocytic leukemia: a phase II study (P-H482) of the Eastern Cooperative Oncology Group, LEUK LYMPH, 35(3-4), 1999, pp. 375-377
Authors:
Hochster, H
Strawderman, MH
Harris, JE
Atkins, MB
Oken, M
Skeel, RT
Jubelirer, SJ
Parkinson, D
Citation: H. Hochster et al., Conventional dose melphalan is inactive in metastatic melanoma: results ofan Eastern Cooperative Oncology Group Study (E1687), ANTI-CANC D, 10(2), 1999, pp. 245-248
Authors:
Plate, JMD
Shott, S
Harris, JE
Citation: Jmd. Plate et al., Immunoregulation in pancreatic cancer patients, CANCER IMMU, 48(5), 1999, pp. 270-279